Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by infiltrates of lipid-laden CD68+/CD1a− histiocytes, affecting heart, lungs, central nervous system, and bones. Kidney and adjacent structures can also be affected, leading to renal failure in about 30% of case...
Saved in:
Main Authors: | Manuel Alfredo Podestà (Author), Giorgio Graziani (Author), Francesco Reggiani (Author), Michele Buemi (Author), Salvatore Badalamenti (Author), Claudio Ponticelli (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erdheim-Chester disease BRAF (-) Diagnosis through cutaneous manifestations and good response with anakinra treatment
by: Juan-Manuel, et al.
Published: (2024) -
Erdheim-Chester Disease
by: Melissa Matzumura MD, et al.
Published: (2016) -
Everolimus in Erdheim-Chester disease
by: Mohamed A. Hussein, et al.
Published: (2013) -
Updates on Erdheim-Chester disease
by: Ismail Elbaz Younes, et al.
Published: (2022) -
Erdheim - Chester disease: Clinical pearls for the anesthesiologist
by: Uma Hariharan, et al.
Published: (2014)